Seagen
SGEN
$228.74
Share price
-0.07%
Change (1 day)
68.92%
Change (1 year)
Categories
EPS for Seagen (SGEN)
EPS in 2023 (TTM): -$4.01
According to Seagen 's latest financial reports the company's current EPS (TTM) is -$4.01. In 2022 the company made an earnings per share (EPS) of -$3.30 an increase over its 2021 EPS that were of -$3.70.
EPS history for Seagen from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.01 | 21.52% |
| 2022 | -$3.30 | -10.81% |
| 2021 | -$3.70 | -206.32% |
| 2020 | $3.48 | -458.76% |
| 2019 | -$0.97 | -31.69% |
| 2018 | -$1.42 | 63.22% |
| 2017 | -$0.87 | -13% |
| 2016 | -$1.00 | 6.38% |
| 2015 | -$0.94 | 51.61% |
| 2014 | -$0.62 | 19.23% |
| 2013 | -$0.52 | 10.64% |
| 2012 | -$0.47 | -64.66% |
| 2011 | -$1.33 | 101.52% |
| 2010 | -$0.66 | -27.47% |
| 2009 | -$0.91 | -15.74% |
| 2008 | -$1.08 | 36.71% |
| 2007 | -$0.79 | 5.33% |
| 2006 | -$0.75 | 5.63% |
| 2005 | -$0.71 | -59.89% |
| 2004 | -$1.77 | 139.19% |
| 2003 | -$0.74 | -3.9% |
| 2002 | -$0.77 | -24.51% |
| 2001 | -$1.02 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -146.38% | 🇺🇸 USA |
 AbbVie ABBV | $3.68 | -191.79% | 🇺🇸 USA |
 Biogen BIIB | $18.46 | -560.35% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -199.00% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -187.30% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | -$0.36 | -91.02% | 🇺🇸 USA |
 ImmunoGen
IMGN | -$0.31 | -92.27% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$2.40 | -40.15% | 🇺🇸 USA |